Mucormycosis is a serious, fast-moving fungal infection caused by a group of common molds found in soil, decaying organic matter, and the air around us. Most healthy immune systems neutralize these molds without trouble, but in people with weakened defenses, the fungi can invade tissue, destroy blood vessels, and kill surrounding tissue rapidly. Overall mortality sits around 33%, though that number varies sharply depending on where in the body the infection takes hold and how quickly treatment begins.
How the Infection Works
The fungi responsible belong to a group called Mucorales, with Rhizopus species being the most common culprit. Other species in the Mucor, Cunninghamella, and Lichtheimia families can also cause disease. These molds are everywhere in the environment, thriving in soil, compost piles, and rotting fruit. People breathe in microscopic spores daily without consequence.
What makes mucormycosis so dangerous in vulnerable people is the way the fungus behaves once it gains a foothold. It invades blood vessel walls directly, triggering clots that block blood flow to surrounding tissue. Without blood supply, that tissue dies. This cascading process of vessel invasion, clotting, and tissue death is the hallmark of the disease and explains why it progresses so quickly. It also creates a vicious cycle: dead tissue can’t deliver antifungal medication carried in the bloodstream, which means drugs alone often can’t keep up with the infection.
Who Is Most at Risk
Uncontrolled diabetes is the single most recognized risk factor, particularly when blood sugar spirals into a crisis called diabetic ketoacidosis. The connection is surprisingly specific. When blood becomes acidic during ketoacidosis, a protein called transferrin loses its ability to lock up iron. Normally, transferrin keeps iron bound and unavailable, which starves fungi of a nutrient they need to grow. In lab experiments, blood from people in ketoacidosis with higher iron levels supported heavy fungal growth, while normal blood at a healthy pH did not support any growth at all. Correcting the acidosis restored that protective iron-binding capacity.
Beyond diabetes, other high-risk groups include people with blood cancers, organ transplant recipients on immune-suppressing medications, people with very low white blood cell counts, and those on long-term corticosteroid therapy. Burn patients and people with significant skin trauma are vulnerable to the skin form of the disease, and notably, this form can strike even people with normal immune function if the fungus enters through broken skin.
Five Forms of Mucormycosis
Rhinocerebral (Sinus and Brain)
This is the most common form, especially in people with diabetes. It starts in the sinuses and can spread to the eye sockets and brain. Early symptoms include one-sided facial swelling, headache, sinus congestion or pain, bloody nasal discharge, and fever. As the infection advances, the eyelid may droop, the eye may bulge forward, eye movement becomes limited, and vision deteriorates. Black, dead-looking lesions on the roof of the mouth or inside the nose, and dark discharge from the eyes, are telltale signs that tissue destruction is underway.
Pulmonary (Lung)
Lung infections are most common in people with blood cancers or severely low white blood cell counts. Symptoms are frustratingly nonspecific: fever, cough, chest pain, and shortness of breath. As the fungus invades lung blood vessels, tissue dies and can form cavities. Coughing up blood may follow. This form carried a relatively lower mortality rate of 15% in one study, likely because the lungs allow more effective surgical and medical access.
Cutaneous (Skin)
Skin mucormycosis occurs when fungal spores enter through wounds, burns, or other breaks in the skin. It can happen even in people who aren’t immunocompromised. The infected area becomes red, swollen, and painful, with pus and abscess formation. Over time, the skin turns into a black, crusty wound as tissue dies. A secondary skin form can also develop when the fungus spreads through the bloodstream from another infection site.
Gastrointestinal
This less common form results from swallowing the fungus and tends to affect malnourished individuals and premature infants. The stomach, colon, and small intestine are the usual targets. Symptoms include abdominal pain, bloating, nausea, vomiting, and possible gastrointestinal bleeding. In newborns, it closely mimics a more common bowel condition, making it especially difficult to diagnose.
Disseminated
When mucormycosis enters the bloodstream and spreads to multiple organs, it becomes disseminated. This usually develops from a lung infection in people with very low white blood cell counts. The brain is the most common destination, but the spleen, heart, and skin can all be affected. Disseminated disease carries by far the worst prognosis. In one study, it was independently associated with a dramatically increased risk of death compared to localized forms.
How It Is Diagnosed
There is no simple blood test for mucormycosis. Diagnosis relies heavily on tissue biopsy, where a sample of infected tissue is examined under a microscope. The fungal threads have a distinctive appearance: wide, ribbon-like strands measuring 5 to 20 micrometers across, with few or no internal dividing walls, branching at right angles. Pathologists look for these characteristic threads alongside evidence of clotted blood vessels and dying tissue. Imaging studies like CT scans can reveal the extent of tissue destruction, particularly in sinus and lung infections, but they can’t confirm the diagnosis on their own.
Speed matters enormously. The infection advances quickly enough that delays of even a day or two can mean the difference between a contained infection and one that has spread beyond the reach of treatment.
Treatment: Surgery Comes First
Unlike many infections where medication is the primary weapon, mucormycosis demands aggressive surgery as the cornerstone of treatment. Because the fungus destroys blood vessels and kills tissue, antifungal drugs carried in the bloodstream simply cannot reach the infected areas effectively. Surgeons must cut away all dead and infected tissue, sometimes repeatedly, to physically remove the fungus. In limb infections, this can mean amputation. In sinus infections, it may require removing parts of the palate, nasal structures, or eye socket contents.
Complete surgical removal of infected tissue is independently associated with improved survival. One study found it reduced the risk of death at six months significantly compared to incomplete removal or no surgery at all. Antifungal medication works best as a companion to surgery, not a replacement for it.
On the medication side, a lipid-based formulation of amphotericin B is the standard first-line treatment. It is one of only two antifungals approved for mucormycosis. The other, isavuconazole, can be used as a first-line alternative when kidney problems make amphotericin B too risky, or as an add-on when the infection isn’t responding. Posaconazole serves as a salvage option for patients who fail or can’t tolerate other treatments. Notably, several common antifungal drugs, including fluconazole and voriconazole, have little to no effect against these fungi.
Controlling the underlying condition is equally critical. For people with diabetes, bringing blood sugar and acid levels back to normal restores the body’s natural iron-binding defenses and slows the fungal growth that acidic, iron-rich blood was fueling.
Reducing Your Risk
For people who are immunocompromised, complete avoidance of environmental mold spores isn’t realistic, but reducing exposure helps. The CDC recommends avoiding construction sites, excavation areas, and buildings damaged by floods or water leaks. If you can’t avoid dusty environments, wearing an N95 respirator mask offers some protection. Yardwork, gardening, and handling soil, compost, or manure all increase exposure and are worth avoiding during periods of immune suppression.
Good blood sugar control in diabetes is one of the most effective preventive strategies, since it keeps the body’s natural iron-binding defenses intact. For transplant recipients and cancer patients, the immune suppression that makes them vulnerable is often medically necessary, which makes environmental precautions and close monitoring all the more important.